市場調查報告書
商品編碼
1189806
血管造影市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)Angiography Devices Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
心血管疾病,包括心髒病發作和中風等心血管疾病,是過早死亡的第一大原因。
根據世界衛生組織 (WHO) 的數據,2017 年心血管疾病每年導致約 1790 萬人死亡,預計到 2030 年這一數字將增加到 2360 萬以上。 因此,心血管疾病的增加可能會推動對血管造影設備的需求,並最終導致血管造影設備市場的增長。 此外,技術的快速進步、公眾意識的提高以及對微創手術的高度偏好等其他因素也補充了市場增長。
醫院部門佔據主導地位的主要驅動因素是更高的患者容量、更好的資源可用性、多樣化的地理覆蓋範圍、配套醫療基礎設施和程序的可用性、熟練勞動力的可用性、政府資金的可負擔性。 在發達市場和新興市場,隨著心血管疾病死亡人數的增加,複雜心髒病病例的數量也在增加。 與專科診所相比,醫院因其更好的可及性和可負擔性而吸引了更多的心血管疾病患者。 由於受益於大宗採購折扣以及與製造商和供應商的貿易協議,該醫院的利潤指數也在改善。 此外,這些貿易協定將為製造商及早獲得及時升級和技術先進的產品開闢新途徑,從而提高醫院的治療能力。
由於微創手術的高采用率、報銷制度的加強、老年人口的增長以及醫療設備的高更換率,北美在血管造影市場佔據主導地位。 強大的醫療器械公司網絡、遍布城市和州的大量醫院以及獲得融資機會是該地區市場主導地位的主要驅動力。 此外,政府機構的大力支持促進了該地區醫療保健部門心血管疾病整體治療所需的發展。
歐洲是僅次於北美的第二大市場。 歐洲國家的很大份額歸因於心血管疾病患病率高、政府投資高、產品批准過程加快以及許多血管造影篩查程序到位而導致血管造影設備的採用率上升。
血管造影市場正在整合且競爭激烈。 一些全球參與者主導著市場,這主要是由於嚴格的產品審批流程和對重要技術能力的需求。 主要市場參與者包括 AngioDynamics Inc.、波士頓科學公司、佳能醫療系統公司、Cardinal Health Inc.、GE Healthcare、Medtronic PLC、Koninklijke Philips NV、Shimadzu Corporation、Siemens Healthineers AG 和 Terumo Corporation。
The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths. According to the World Health Organization, 2017, cardiovascular diseases account for nearly 17.9 million deaths per year, and this number is expected to grow to more than 23.6 million by 2030. Hence, the increasing number of cardiovascular diseases is driving the demand for angiography devices, which may ultimately result in the growth of the angiography devices market. Furthermore, other factors, such as rapid technological advances, increasing awareness of the population, and a high preference for minimally invasive procedures, are supplementing the market growth.
The main factors attributing to the dominance of the hospital segment are the availability of the larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labor, and affordability via government funding. A large number of complex cardiac disease cases are on the rise, with the growth in the number of deaths due to cardiovascular diseases, across both the developed and emerging markets. The high accessibility and affordability of hospitals, as compared to the specialty clinics, attract a large patient population suffering from cardiovascular diseases. The profitability index of hospitals also increases, as they benefit from the bulk purchase discounts and trade agreements with the manufacturers and suppliers. Furthermore, these trade agreements open new avenues to timely upgradation and early access to technologically advanced products by the manufacturers, enhancing the hospital's treatment capability.
North America dominates the angiography devices market, owing to the high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, and high replacement rates of medical equipment. Factors, such as a good network of medical device companies and a large number of hospitals across cities and states with good funding opportunities, primarily help the region dominate the market. Furthermore, good support from government facilities helps in the development required for the overall treatment of cardiovascular diseases in the healthcare sector of the region.
Europe is the second-largest market after North America. The significant share of the European countries can be attributed to the high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures being performed.
The angiography devices market is consolidated and highly competitive. A few global players dominate the market, primarily due to the stringent product approval process, along with the need for significant technological capabilities. The key market players include AngioDynamics Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, and Terumo Corporation.